Alembic Profit & Loss Annual

Trade
BSE: 506235 | NSE: ALEMBICLTD | ISIN: INE426A01027 | Sector: Biotechnology & Drugs
126.65 +2.50 (2.01%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 157.49127.2478.2273.52
Total Revenue 157.49127.2478.2273.52
Costof Revenue Total 48.9645.0225.0824.29
Gross Profit 108.5382.2253.1449.22
Selling/ General/ Admin Expenses Total 23.0340.1837.5136.58
Depreciation/ Amortization 7.841.731.781.51
Other Operating Expenses Total 28.631.711.701.58
Total Operating Expense 108.46104.2468.7866.39
Operating Income 49.0323.009.447.13
Interest Inc( Exp) Net- Non- Op Total -11.10598.88820.0061.08
Other Net 54.772.884.463.56
Net Income Before Taxes 102.6986.8097.8617.04
Provisionfor Income Taxes 9.826.1811.663.20
Net Income After Taxes 92.8780.6286.1913.84
Equity In Affiliates 1,757.501,100.301,358.653,290.04
Net Income Before Extra Items 268.62190.65222.06342.84
Net Income 268.62190.65222.06342.84
Income Availableto Com Excl Extra Ord 268.62190.65222.06342.84
Income Availableto Com Incl Extra Ord 268.62190.65222.06342.84
Diluted Net Income 268.62190.65222.06342.84
Diluted Weighted Average Shares 25.6825.6825.6825.68
Diluted EPS Excluding Extra Ord Items 10.467.428.6513.35
DPS- Common Stock Primary Issue 2.402.201.800.20
Diluted Normalized EPS 10.467.778.5713.34
Interest Exp( Inc) Net- Operating Total -49.9530.8224.27
Unusual Expense( Income) -10.61-0.37-
Gain( Loss)on Saleof Assets -10.2619.582.44
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts